199 related articles for article (PubMed ID: 12137927)
1. Regulation of norepinephrine transporter abundance by catecholamines and desipramine in vivo.
Weinshenker D; White SS; Javors MA; Palmiter RD; Szot P
Brain Res; 2002 Aug; 946(2):239-46. PubMed ID: 12137927
[TBL] [Abstract][Full Text] [Related]
2. Chronic desipramine treatment alters tyrosine hydroxylase but not norepinephrine transporter immunoreactivity in norepinephrine axons in the rat prefrontal cortex.
Erickson SL; Gandhi AR; Asafu-Adjei JK; Sampson AR; Miner L; Blakely RD; Sesack SR
Int J Neuropsychopharmacol; 2011 Oct; 14(9):1219-32. PubMed ID: 21208501
[TBL] [Abstract][Full Text] [Related]
3. Topographic comparison of the expression of norepinephrine transporter, tyrosine hydroxylase and neuropeptide Y mRNA in association with dopamine beta-hydroxylase neurons in the rabbit brainstem.
Pau KY; Ma YJ; Yu JH; Yang SP; Airhart N; Spies HG
Brain Res Mol Brain Res; 1997 Sep; 48(2):367-81. PubMed ID: 9332734
[TBL] [Abstract][Full Text] [Related]
4. Neurotrophin-3- and norepinephrine-mediated adrenergic differentiation and the inhibitory action of desipramine and cocaine.
Zhang JM; Dix J; Langtimm-Sedlak CJ; Trusk T; Schroeder B; Hoffmann R; Strosberg AD; Winslow JW; Sieber-Blum M
J Neurobiol; 1997 Mar; 32(3):262-80. PubMed ID: 9058320
[TBL] [Abstract][Full Text] [Related]
5. Tyrosine depletion lowers dopamine synthesis and desipramine-induced prefrontal cortex catecholamine levels.
Bongiovanni R; Newbould E; Jaskiw GE
Brain Res; 2008 Jan; 1190():39-48. PubMed ID: 18082673
[TBL] [Abstract][Full Text] [Related]
6. Effects of desipramine treatment on tyrosine hydroxylase gene expression in cultured neuroblastoma cells and rat brain tissue.
Zhu MY; Wang WP; Baldessarini RJ; Kim KS
Brain Res Mol Brain Res; 2005 Feb; 133(2):167-75. PubMed ID: 15710233
[TBL] [Abstract][Full Text] [Related]
7. Possible involvement of norepinephrine transporter activity in the pulsatility of hypothalamic gonadotropin-releasing hormone release: influence of the gonad.
Pau KY; Lee CJ; Cowles A; Yang SP; Hess DL; Spies HG
J Neuroendocrinol; 1998 Jan; 10(1):21-9. PubMed ID: 9510055
[TBL] [Abstract][Full Text] [Related]
8. Effects of desipramine treatment on norepinephrine transporter gene expression in the cultured SK-N-BE(2)M17 cells and rat brain tissue.
Zhu MY; Kim CH; Hwang DY; Baldessarini RJ; Kim KS
J Neurochem; 2002 Jul; 82(1):146-53. PubMed ID: 12091475
[TBL] [Abstract][Full Text] [Related]
9. Inverse blood pressure rhythm of transgenic hypertensive TGR(mREN2)27 rats: role of norepinephrine and expression of tyrosine-hydroxylase and reuptake1-transporter.
Lemmer B; Schiffer S; Witte K; Gorbey S
Chronobiol Int; 2005; 22(3):473-88. PubMed ID: 16076648
[TBL] [Abstract][Full Text] [Related]
10. Use of dopamine-beta-hydroxylase-deficient mice to determine the role of norepinephrine in the mechanism of action of antidepressant drugs.
Cryan JF; Dalvi A; Jin SH; Hirsch BR; Lucki I; Thomas SA
J Pharmacol Exp Ther; 2001 Aug; 298(2):651-7. PubMed ID: 11454927
[TBL] [Abstract][Full Text] [Related]
11. Effects of dopamine beta-hydroxylase genotype and disulfiram inhibition on catecholamine homeostasis in mice.
Bourdélat-Parks BN; Anderson GM; Donaldson ZR; Weiss JM; Bonsall RW; Emery MS; Liles LC; Weinshenker D
Psychopharmacology (Berl); 2005 Nov; 183(1):72-80. PubMed ID: 16163519
[TBL] [Abstract][Full Text] [Related]
12. Ultrastructural interactions between terminals expressing the norepinephrine transporter and dopamine neurons in the rat and monkey ventral tegmental area.
Liprando LA; Miner LH; Blakely RD; Lewis DA; Sesack SR
Synapse; 2004 Jun; 52(4):233-44. PubMed ID: 15103690
[TBL] [Abstract][Full Text] [Related]
13. Chronic depolarization stimulates norepinephrine transporter expression via catecholamines.
Habecker BA; Willison BD; Shi X; Woodward WR
J Neurochem; 2006 May; 97(4):1044-51. PubMed ID: 16573647
[TBL] [Abstract][Full Text] [Related]
14. Inhibition by neuromuscular blocking drugs of norepinephrine transporter in cultured bovine adrenal medullary cells.
Uryu K; Minami K; Yanagihara N; Hara K; Toyohira Y; Izumi F; Shigematsu A
Anesth Analg; 2000 Sep; 91(3):546-51. PubMed ID: 10960373
[TBL] [Abstract][Full Text] [Related]
15. Desipramine treatment decreases 3H-nisoxetine binding and norepinephrine transporter mRNA in SK-N-SHSY5Y cells.
Zavosh A; Schaefer J; Ferrel A; Figlewicz DP
Brain Res Bull; 1999 Jul; 49(4):291-5. PubMed ID: 10424850
[TBL] [Abstract][Full Text] [Related]
16. Astroglial dopamine transport is mediated by norepinephrine transporter.
Takeda H; Inazu M; Matsumiya T
Naunyn Schmiedebergs Arch Pharmacol; 2002 Dec; 366(6):620-3. PubMed ID: 12444505
[TBL] [Abstract][Full Text] [Related]
17. Desipramine attenuates working memory impairments induced by partial loss of catecholamines in the rat medial prefrontal cortex.
Clinton SM; Sucharski IL; Finlay JM
Psychopharmacology (Berl); 2006 Jan; 183(4):404-12. PubMed ID: 16307295
[TBL] [Abstract][Full Text] [Related]
18. Effects of catecholamine uptake blockers in the caudate-putamen and subregions of the medial prefrontal cortex of the rat.
Mazei MS; Pluto CP; Kirkbride B; Pehek EA
Brain Res; 2002 May; 936(1-2):58-67. PubMed ID: 11988230
[TBL] [Abstract][Full Text] [Related]
19. Pontine norepinephrine defects in Mecp2-null mice involve deficient expression of dopamine beta-hydroxylase but not a loss of catecholaminergic neurons.
Zhang X; Su J; Rojas A; Jiang C
Biochem Biophys Res Commun; 2010 Apr; 394(2):285-90. PubMed ID: 20193660
[TBL] [Abstract][Full Text] [Related]
20. The persistent membrane retention of desipramine causes lasting inhibition of norepinephrine transporter function.
Zhu MY; Kyle PB; Hume AS; Ordway GA
Neurochem Res; 2004 Feb; 29(2):419-27. PubMed ID: 15002740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
